ArticleIn vivo (Athens, Greece)

Risk Factors for Delayed Elimination of Methotrexate in Children, Adolescents and Young Adults With Osteosarcoma.

K O Misaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.